Page last updated: 2024-12-07

wr 242511

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

WR 242511: RN given refers to parent cpd [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID133658
CHEMBL ID18679
MeSH IDM0188079

Synonyms (12)

Synonym
n4-(5-hexoxy-6-methoxy-4-methyl-8-quinolyl)pentane-1,4-diamine
(4-amino-1-methylbutyl)(5-hexyloxy-6-methoxy-4-methyl(8-quinolyl))amine
wr242511
wr 242511
wr-242511
CHEMBL18679
1,4-pentanediamine, n4-(5-(hexyloxy)-6-methoxy-4-methyl-8-quinolinyl)-
81358-96-5
n4-(5-(hexyloxy)-6-methoxy-4-methyl-8-quinolinyl)-1,4-pentanediamine
FT-0775259
DTXSID301001947
n~4~-[5-(hexyloxy)-6-methoxy-4-methylquinolin-8-yl]pentane-1,4-diamine

Research Excerpts

Overview

WR 242511 (or I) is a new compound of the 8-aminoquinoline class designed to replace primaquine for the treatment of malaria.

ExcerptReferenceRelevance
"WR 242511 (or I) is a new compound of the 8-aminoquinoline class designed to replace primaquine for the treatment of malaria. "( High-performance liquid chromatographic method for the determination of a candidate 8-aminoquinoline antimalarial drug (WR 242511) using oxidative electrochemical detection.
Brewer, TG; Marino, MT; Peggins, JO, 1993
)
1.94

Pharmacokinetics

ExcerptReferenceRelevance
" Elimination half-life for the drug was 30 +/- 14 hr."( Pharmacokinetics and kinetic-dynamic modeling of an 8-aminoquinoline candidate anticyanide and antimalarial drug (WR242511).
Brewer, TG; Brown, LD; Marino, MT; Peggins, JO; Urquhart, MR,
)
0.13
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Bioassays (16)

Assay IDTitleYearJournalArticle
AID162092Minimal effective concentration inhibiting growth of Pneumocystis carinii was reported.1995Journal of medicinal chemistry, Nov-24, Volume: 38, Issue:24
New drug developments for opportunistic infections in immunosuppressed patients: Pneumocystis carinii.
AID126317Cures in Plasmodium cynomolgi infected Rhesus monkeys (Macaca mulatta) on 3.16 mg/kg/day after 7 days; cured 0 of 11987Journal of medicinal chemistry, Jul, Volume: 30, Issue:7
Modifications of primaquine as antimalarials. 4. 5-Alkoxy derivatives of primaquine.
AID126177Radical curative antimalarial activity against Plasmodium cynomolgi in Rhesus monkeys (Macaca mulatta) at 0.1 mg/kg/day over 7 days; cured 5 of 51987Journal of medicinal chemistry, Jul, Volume: 30, Issue:7
Modifications of primaquine as antimalarials. 4. 5-Alkoxy derivatives of primaquine.
AID126307Cures in Plasmodium cynomolgi infected Rhesus monkeys (Macaca mulatta) on 1 mg/kg/day after 7 days; cured 1 of 11987Journal of medicinal chemistry, Jul, Volume: 30, Issue:7
Modifications of primaquine as antimalarials. 4. 5-Alkoxy derivatives of primaquine.
AID129590Suppressive blood schizonticidal antimalarial activity evaluated in the trophozoite-induced Plasmodium berghei infection in mice (Mus musculus) at a dose 5 mg/kg given as no. of cures1987Journal of medicinal chemistry, Jul, Volume: 30, Issue:7
Modifications of primaquine as antimalarials. 4. 5-Alkoxy derivatives of primaquine.
AID126304Cures in Plasmodium cynomolgi infected Rhesus monkeys (Macaca mulatta) on 0.316 mg/kg/day after 7 days; cured 3 of 31987Journal of medicinal chemistry, Jul, Volume: 30, Issue:7
Modifications of primaquine as antimalarials. 4. 5-Alkoxy derivatives of primaquine.
AID129585Suppressive blood schizonticidal antimalarial activity evaluated in the trophozoite-induced Plasmodium berghei infection in mice (Mus musculus) at a dose 2.5 mg/kg given as number of cures1987Journal of medicinal chemistry, Jul, Volume: 30, Issue:7
Modifications of primaquine as antimalarials. 4. 5-Alkoxy derivatives of primaquine.
AID139868Suppressive blood schizonticidal antimalarial activity evaluated in the trophozoite-induced Plasmodium berghei infection in mice (Mus musculus) at a dose 320 mg/kg given as no. of toxic deaths1987Journal of medicinal chemistry, Jul, Volume: 30, Issue:7
Modifications of primaquine as antimalarials. 4. 5-Alkoxy derivatives of primaquine.
AID496819Antimicrobial activity against Plasmodium falciparum2010Bioorganic & medicinal chemistry, Mar-15, Volume: 18, Issue:6
Multi-target spectral moment QSAR versus ANN for antiparasitic drugs against different parasite species.
AID139866Suppressive blood schizonticidal antimalarial activity evaluated in the trophozoite-induced Plasmodium berghei infection in mice (Mus musculus) at a dose 160 mg/kg given as no. of toxic deaths1987Journal of medicinal chemistry, Jul, Volume: 30, Issue:7
Modifications of primaquine as antimalarials. 4. 5-Alkoxy derivatives of primaquine.
AID129592Suppressive blood schizonticidal antimalarial activity evaluated in the trophozoite-induced Plasmodium berghei infection in mice (Mus musculus) at a dose 80 mg/kg given as no. of cures1987Journal of medicinal chemistry, Jul, Volume: 30, Issue:7
Modifications of primaquine as antimalarials. 4. 5-Alkoxy derivatives of primaquine.
AID1850873Antileishmanial activity against Leishmania mexicana 227 assessed as inhibition of parasite viability
AID139870Suppressive blood schizonticidal antimalarial activity evaluated in the trophozoite-induced Plasmodium berghei infection in mice (Mus musculus) at a dose 640 mg/kg given as number of toxic deaths1987Journal of medicinal chemistry, Jul, Volume: 30, Issue:7
Modifications of primaquine as antimalarials. 4. 5-Alkoxy derivatives of primaquine.
AID129586Suppressive blood schizonticidal antimalarial activity evaluated in the trophozoite-induced Plasmodium berghei infection in mice (Mus musculus) at a dose 20 mg/kg given as no. of cures1987Journal of medicinal chemistry, Jul, Volume: 30, Issue:7
Modifications of primaquine as antimalarials. 4. 5-Alkoxy derivatives of primaquine.
AID129583Suppressive blood schizonticidal antimalarial activity evaluated in the trophozoite-induced Plasmodium berghei infection in mice (Mus musculus) at a dose 10 mg/kg given as no. of cures1987Journal of medicinal chemistry, Jul, Volume: 30, Issue:7
Modifications of primaquine as antimalarials. 4. 5-Alkoxy derivatives of primaquine.
AID129589Blood schizonticidal activity in trophozoite-induced Plasmodium berghei infected mice (Mus musculus) at 40 mg/kg; numbers cured1987Journal of medicinal chemistry, Jul, Volume: 30, Issue:7
Modifications of primaquine as antimalarials. 4. 5-Alkoxy derivatives of primaquine.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (10)

TimeframeStudies, This Drug (%)All Drugs %
pre-19901 (10.00)18.7374
1990's6 (60.00)18.2507
2000's1 (10.00)29.6817
2010's1 (10.00)24.3611
2020's1 (10.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 12.49

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index12.49 (24.57)
Research Supply Index2.48 (2.92)
Research Growth Index4.97 (4.65)
Search Engine Demand Index0.00 (26.88)
Search Engine Supply Index0.00 (0.95)

This Compound (12.49)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews1 (9.09%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other10 (90.91%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]